Research Notes

Stay informed with the most recent market and company research insights.

A man sitting at a table with a glass of orange juice.

Research Notes

Soul searching for private opportunities

WH Soul Pattinson & Co
3:27pm
March 24, 2025
SOL released its 1H25 result, which in our view highlighted a broadly resilient performance of the investment portfolio in terms of its cash generation in the period. Management were active, with ~A$1.9bn worth of transactions being conducted and further allocation to private asset classes. Key contributions from its core strategic holdings, Private Equity and the Credit portfolio helped grow SOL’s net cash from investments 10% on pcp to ~A$290m. A 44cps fully-franked interim dividend was declared (25 consecutive years of dividend increases). Our DDM/SOTP-derived price target is largely unchanged at A$36.20 (from A$36.30). Our changes to forecasts are overleaf. We continue to like the SOL story, particularly its track record of growing distributions and history of uncorrelated and above market returns. We maintain our Add recommendation.

Phase 3 disappoints; DFA uncertainty

Opthea
3:27pm
March 24, 2025
After 7 days in trading halt/suspension, the company released highly anticipated top line results from the Phase 3 COAST trial, showing lead drug candidate sozinibercept combined with standard of care (SOC) eylea failed to show an improvement in mean change in best correct visual acuity (BCVA), the primary endpoint. Sozinibercept also did not demonstrate any numerical difference across key secondary endpoints compared to SOC. Management is accessing its obligations under a 2002 inked development funding agreement (DFA), where the company may be required to pay amounts that could have a material adverse impact on its solvency.

International Spotlight

Nike Inc
3:27pm
March 24, 2025
Nike, Inc. is a global leader in athletic footwear, apparel and equipment with an estimated market share in 2023 of 39% (investing.com). Nike’s iconic ‘Swoosh’ logo is one of the most recognisable consumer brands in the world. Nike sells directly through over 1,000 retail stores and ecommerce platforms, as well as through wholesale channels. It employs a contract manufacturing model.

Just scratching the surface

Turaco Gold
3:27pm
March 23, 2025
Turaco Gold (TCG) owns the rapidly growing 2.52Moz Afema Gold Project (80%) located in Cote d’Ivoire, Africa’s premier gold mining jurisdiction. Afema stands out to us as the one of the most promising emerging gold assets on the ASX, with imminent resource expansion, multi-million-ounce exploration upside, and a clear pathway toward future mining operations. TCG has an experienced board with a track record of delivering value through discovery, mine development, and M&A in the region. We initiate coverage with a SPECULATIVE BUY recommendation and price target of A$1.05ps.

CEO presentation

Transurban Group
3:27pm
March 21, 2025
We hosted the Transurban CEO in our morning meeting this week. Key topics were company strategy, NSW toll reform, medium term cashflow drivers, and capital management. TCL remains leveraged to population/economic growth trends in its regional markets and the value of time (via time savings and reliability). HOLD retained.

Getting positioned for the O&G DDR wave rolling in

Cleanaway Waste Management
3:27pm
March 21, 2025
While we prefer CWY to deploy capital into its leading Solid Waste Services segment, we do find attributes of the CR acquisition appealing given the price paid and how it helps CWY get positioned for the wave of oil & gas decommissioning, decontamination and remediation work expected to eventuate over time. CWY's recent share price decline improved its value attraction. While the stock has lifted off these recent lows we think there is more to come and upgrade to ADD. 12 month target price upgraded to $2.95 (+4%). Potential TSR c.14%.

Eyes on the prize

ALS Limited
3:27pm
March 21, 2025
The shares have underperformed this week as attention has turned to pricing pressure in geochemistry (not new), geochemistry volumes merely seeing “green shoots” (before commencement of the main drilling season in the Northern Hemisphere), and potential negative impacts on the US Environment business due to the Trump administration (not material). This has raised questions about ALQ’s ability to meet FY25 expectations. We believe this is misguided. Volumes in geochemistry have ticked up (albeit only slightly) and there should be a material swing in FX from 1H (-$15m EBIT) to 2H (positive FX). Consensus is forecasting 2H EBIT ($260m) to be down $5m from 1H constant FX EBIT ($265m). At the same time, the backdrop for the key Commodities business continues to improve. The stock is trading on 21x FY26F PE which is well below IMD (26x) and not reflective of the outlook. We see recent weakness as a buying opportunity. Target price moves to $17.50 (from $16.75).

Strategic re-alignment and capital raise

Micro-X
3:27pm
March 21, 2025
MX1 has moved its focus to medical imaging for its cold cathode x-ray technology, with further work on the Argus being halted after the commercial launch didn’t attract sufficient customer interest. We are supportive of this pivot. A strategic investment, a capital raise and project income from ARPA-H help replace the lost revenue from the Argus and improve the cash position to enable MX1 to realign its business focus. Our TP reduces to A$0.17 (was A$0.19) We maintain our Speculative Buy recommendation.

Start of the next era

Sigma Healthcare Ltd
3:27pm
March 20, 2025
SIG posted its final result as a stand-alone company which was in line with guidance. We now move to adjust our model to fully reflect the merged entity with a June Year End, which sees a modest increase in our forecasts. As a result, our valuation has increased slightly to A$2.40 (was A$2.31). We have maintained a 30% liquidity premium reflecting expected passive buying from index funds to derive our target price of A$3.12. We maintain our Add recommendation for clients looking for a quality growth company.

Cyclical trough approaching

Brickworks
3:27pm
March 20, 2025
As largely foreshowed in the 11-March trading update, BKW’s 1H25 result was weak, as Property saw EBITDA (ex-revals) decline on the back of lower development profits, whilst Building Materials was impacted by lower demand and Investments saw a slight moderation in investment returns. Nonetheless, BKW was able to increase the dividend 1 cps to 25 cps (in line with our forecasts). As we look forward, we struggle to see catalysts for BKW, with investment market uncertainty likely to outweigh any potential tailwinds from industrial real estate rental income. We retain our Hold rating, with a $26.50/sh price target.

News & Insights

Michael Knox, Chief Economist, reveals how the OECD and RBA’s outdated assumptions about global trade fail to account for China’s Marxist-Leninist economic strategies.

This morning, I was asked to discuss Sarah Hunter’s presentation from yesterday. Sarah, the Assistant Governor and Chief Economist at the Reserve Bank of Australia (RBA), delivered a detailed and competent discussion on the conventional view of tariffs’ impact on the international economy. She highlighted that tariffs typically increase inflation and reduce economic output, a perspective echoed by the OECD in a similar presentation overnight. Sarah’s analysis focused on the potential shocks tariffs could cause, particularly their effects on GDP and inflation.

Drawing on my experience as an Australian trade commissioner and my work in Australian embassies, I found her presentation particularly interesting. My background allowed me to bring specialist knowledge to the conversation, which I believe gave me an edge. Notably, I observed that the RBA seems to lack analysts closely tracking individual policymakers in the Trump administration, such as Scott Bessent, whose views on tariffs and competition differ from the general assumptions. The conventional view assumes a world of perfectly competitive countries adhering to international trade rules and unlikely to engage in conflict—a scenario that doesn’t align with the current global trade environment, especially between China and the United States.

China, operating as a Marxist-Leninist economy, aims to dominate global markets by building monopolies in areas like rare earths, nickel, copper, and other base metals. It maintains a managed exchange rate, despite promises to the International Monetary Fund for a freely floating currency. If China allowed its currency, the RMB, to float, it would likely appreciate significantly, increasing imports and reducing its trade surplus. This would create a more balanced international trade environment, potentially reducing the need for other countries to impose tariffs. However, major institutions like the OECD and RBA seem to misjudge the nature of this trade shock, relying on outdated assumptions about global trade dynamics.

The international community also appears to overlook specific U.S. policy intentions, such as those articulated by figures like Peter Navarro and Scott Bessent. The U.S. aims to use tariffs selectively to bolster industries like pharmaceuticals, precision manufacturing, and motor vehicles. This misunderstanding leads public institutions to perceive unspecified risks, as reflected in Sarah’s otherwise able presentation. Because the RBA and similar institutions view the world as fraught with undefined risks, they are inclined to keep interest rates low, responding to perceived threats rather than an equilibrium model.

Interestingly, data from the U.S. economy contradicts the expected negative impacts of tariffs. The Chicago Fed National Activity Indicator, a reliable gauge of economic growth since the 2008 financial crisis, shows U.S. growth above the long-term trend for the first four months of this year. This suggests resilience despite tariff-related shocks. Ideally, growth will slow later this year, prompting the Federal Reserve to cut rates, facilitating a soft landing and a decline in the U.S. dollar to boost global commodity prices. However, this nuanced outlook wasn’t evident in yesterday’s presentation.

Moreover, the anticipated rise in U.S. inflation due to tariffs isn’t materialising. Scott Bessent recently noted that U.S. CPI inflation is lower than expected, with core inflation shown as the (16% trimmed mean) at 3% for the past two months . Core inflation  excluding  food and energy CPI  is only at 2.8%. This suggests that Chinese suppliers are absorbing tariff costs to maintain market share, rather than passing them on as higher prices. Recent Chinese data supports this, showing a slight decline in manufacturing confidence and coal consumption, indicating reduced factory output and electricity use. This points to a modest slowdown in China’s economy. So far the expected negative effects on U.S. prices and output are not occurring.

In summary, the fears expressed by institutions like the RBA and OECD about the Trump administration’s trade policies appear overstated. The U.S. economy is not experiencing the predicted declines in output or increases in inflation. While these effects may emerge later, the current data suggests that the risks are not as severe as anticipated, highlighting a disconnect between theoretical models and real-world outcomes.

Read more
Michael Knox outlines the economic outlook for growth and inflation in the U.S., the Euro area, China, India, and Australia, drawing data from the International Monetary Fund, the Congressional Budget Office, European sources, and his own analysis for Australia.

Today, I’m presenting the first page of my updated presentation, which focuses on GDP growth and inflation expectations for major economies. Before diving into that, I want to clarify a point about U.S. trade negotiations that has confused some media outlets.

In the previous Trump Administration ,there was single trade negotiator, Robert Lighthizer, held a cabinet position with the rank of Ambassador. This time, to expedite negotiations and give them more weight, Trump has appointed two additional cabinet-level officials to handle trade talks with different regions. For Asian economies, Scott Bessent and Ambassador Jamison Greer, who succeeded Lighthizer and previously served on the White House staff, are managing negotiations, including those with China. For Europe, Howard Lutnick, the Commerce Secretary, and Ambassador Greer are negotiating with the European Trade Representative. When the EU representative visits Washington, D.C., they meet with Lutnick and Greer, while Chinese or Japanese representatives engage with Bessent and Greer.

In my presentation today, I’m outlining the economic outlook for growth and inflation in the U.S., the Euro area, China, India, and Australia, drawing data from the International Monetary Fund, the Congressional Budget Office, European sources, and my own analysis for Australia.

For the U.S., the best-case scenario is a soft landing, with growth slowing but remaining positive at 1.3% this year and rising to 1.7% next year. This slowdown allows the Federal Reserve to continue cutting interest rates, leading to a decline in the U.S. dollar. This in turn ,triggers a recovery in commodity prices. These prices have stabilized and are now trending upward, with an expected acceleration as the dollar weakens.

U.S. headline inflation is projected to be just below 3% next year, with higher figures this year driven by tariff effects.



Global Economic Perspective

In the Euro area, growth is accelerating slightly, from just under 1% this year to 1.2% next year, with inflation expected to hit the 2% target this year and dip to 1.9% next year.

China’s GDP growth is forecast  at 4% for both this year and next, a step down from previous 5% rates, reflecting a significant slump in domestic demand and very low inflation  Chinese Inflation is only  :   0.2% last year, 0.4% this year, and 0.9% next year.  Despite a massive fiscal push, with a budget deficit around 8% of GDP, China’s debt-to-GDP ratio is rising faster than the U.S.. Yet this is  yielding more modest  domestic growth.

India, on the other hand, continues to outperform, with 6.5% GDP growth last year, 6.2% this year, and  6.3%  next year, surpassing earlier projections.

Read more
In our International Reporting Season Review, we provide an overview of the March 2025 quarterly results season for companies in the Americas, Europe and Asia.

Positive earnings surprise

In our International Reporting Season Review, we provide an overview of the March 2025 quarterly results season for companies in the Americas, Europe and Asia. For all the volatility in markets caused by US trade policy, the results were positive. For all the 187 high profile and blue-chip companies in our International Watchlist, the median EPS beat vs consensus was 3.2%, nearly twice that recorded in the December quarter (1.8%). 37% of companies exceeded consensus EPS expectations by more than 5% and only 9% missed by more than 5%. Communication Services was the most positive sector, led by Magnificent 7 companies Alphabet and Meta Platforms. The median EPS beat in that sector was 13%. Consumer Discretionary was the biggest disappointment (though only a mild one) with EPS falling 0.6% short of analyst estimates on a median basis.

Alphabet and Meta among the best performers

Across our Watchlist, some of the best performing stocks in terms of EPS beats were Alphabet, Boeing, Uniqlo-owner Fast Retailing, Meta Platforms, Newmont and The Walt Disney Company. Notable misses came from insurance broker Aon, BP, PepsiCo, Starbucks, Tesla and UnitedHealth. The latter saw by far the worst share price performance over reporting season, its earnings weakness compounded by the resignation of its CEO and the launch of a fraud investigation by the Department of Justice. British luxury fashion label Burberry had the best performing share price as it gains traction in its turnaround plan.

Tariffs were the main talking point (of course)

The timing of President Trump’s ‘Liberation Day’ on 2 April, just before the March quarter results started rolling in, guaranteed that US tariffs would be the main talking point throughout reporting season. Most companies took the line that higher tariffs presented a material risk to global growth and inflation. The rapidly shifting sands of US trade policy mean the impact of tariffs is highly uncertain. This didn’t stop many companies from trying to estimate the impact on their profits. This ranged from the very precise ($850m said RTX) to the extremely vague (‘a few hundred million dollars’ hazarded Abbott Laboratories). The rehabilitation of AI as a systemic driver of long-term value was a key theme of reporting season, with many companies reporting what Palantir Technologies described as an ‘unstoppable whirlwind of demand’ and others indicating an increase in planned AI investment. The deterioration in consumer confidence was another key talking point, though most companies could only express concern about a possible future softening in demand rather than any actual evidence of a hit to sales.

Our International Focus List continues to outperform

In this report, we also report on the performance of the Morgans International Focus List, which is now up 25.3% since inception last year, outperforming the benchmark S&P 500 by 20.4%.


Morgans clients receive exclusive insights such as access to our latest International Reporting Season article.

Contact us today to begin your journey with Morgans.

      
Contact us
      
      
Find an adviser
      
Read more